FAPI PET/CT for Ovarian Cancer

(FAST HOC Trial)

UM
FP
Overseen ByFerdous Parveen, MBBS,CCRP
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: University Health Network, Toronto
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The investigator will use a technology called PET-CT that combines a Positron Emission Tomography (PET) scan with a computed tomography (CT) scan. This combined imaging test, where PET and CT data are gathered at one time, will be performed on an integrated PET-CT scanner located at Princess Margaret Cancer Centre.

The purpose of this study is to find out if the use of 68Ga-PNT6555 (FAPI) PET-CT will improve the assessment of disease extent as compared to routine CT scans.

Are You a Good Fit for This Trial?

This trial is for people with suspected or confirmed high-grade serous ovarian cancer (HGSOC) at stage III or IV, who are being considered for surgery or chemotherapy. Participants must have had a recent contrast CT scan of the abdomen and pelvis within the last 6 weeks.

Inclusion Criteria

Contrast-enhanced CT abdomen and pelvis within 6 weeks of PET (prior to enrolment).
I have been diagnosed with or am strongly suspected to have high-grade serous ovarian cancer.
My cancer is stage III or IV and I am being considered for surgery or chemotherapy.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks
1 visit (in-person)

Initial PET/CT Scan

Participants undergo an initial PET/CT scan to assess disease extent

1 day
1 visit (in-person)

Follow-up PET/CT Scan

Participants undergo a follow-up PET/CT scan within six weeks of the initial scan

6 weeks
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after scans

1 year

What Are the Treatments Tested in This Trial?

Interventions

  • 68Ga-PNT6555 (FAPI) PET-CT

Trial Overview

The study is testing whether a new imaging method called FAPI PET-CT can better show how far ovarian cancer has spread compared to standard CT scans. All participants will receive this special PET-CT scan.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: high-grade epithelial ovarian cancers.Experimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University Health Network, Toronto

Lead Sponsor

Trials
1,555
Recruited
526,000+